This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer
Nature Communications Open Access 07 September 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hetz, C., Axten, J. M. & Patterson, J. B. Nat. Chem. Biol. 15, 764–775 (2019).
Tang, C. H. et al. J. Clin. Invest. 124, 2585–2598 (2014).
Shao, A. et al. J. Med. Chem. 62, 5404–5413 (2019).
Xie, H. et al. J. Clin. Invest. 128, 1300–1316 (2018).
Schutt, S. D. et al. Blood Adv. 2, 414–427 (2018).
Tavernier, S. J. et al. Nat. Cell Biol. 19, 698–710 (2017).
Tang, C. H. A. et al. Cancer Immunol. Res. 6, 696–710 (2018).
Betts, B. C. et al. Front. Immunol. 9, 2887 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.R.D. and C.-C.A.H. are named inventors of B-I09 and its analogs (Patent # US10,323,013). All other authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Del Valle, J.R., Betts, B.C., Yu, XZ. et al. Clarifying the translational potential of B-I09. Nat Chem Biol 16, 1152 (2020). https://doi.org/10.1038/s41589-020-00654-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-020-00654-w
This article is cited by
-
Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer
Nature Communications (2021)